
The involvement of patients in regulatory discussions and measuring the needs of patients
Bettina Ryll

Neoadjuvant therapy in bulky Stage III melanoma
Georgina Long

Efficacy of pembrolizumab treatment in mucosal melanoma
Marcus Butler

Cell cycle-dependent resistance or sensitivity to drugs and the importance of MITF genes in melanoma
Nikolas Haass

Current clinical perspectives on targeted therapy and immunotherapy for melanoma
Caroline Robert